ArticlePharmacology research & perspectives2022

mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models.

Lanlan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.